News
August 24, 2011 — The U.S. Department of Health and Human Services (HHS) announced a new initiative to improve care for patients while in the hospital and after discharge. Doctors, hospitals, and other healthcare providers can now apply for a new program known as the Bundled Payments for Care Improvement initiative (Bundled Payments initiative).
August 24, 2011
News
August 24, 2011 -- Radiopharmaceuticals are pharmaceutical agents used to diagnose certain medical problems, such as cardiac, cancer or neurology, and/or treat certain conditions such as cancers. The use of radiopharmaceuticals as tracer dates back to 1930s.
August 24, 2011
News
August 24, 2011 — CardioFocus Inc., developer of the HeartLight endoscopic ablation system (EAS) for the treatment of atrial fibrillation (AF), announced the system is now available in the United Kingdom. The first AF patients were treated at The Heart Hospital in London on Wednesday, August 17, with additional cases to take place throughout the month.
August 24, 2011Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
News
August 24, 2011 — Cleveland HeartLab Inc. (CHL), a specialty clinical laboratory and disease management company, announced the completion of an $18.4-million Series B financing round. The rapidly growing company hopes to further accelerate market adoption of its advanced approach to assessing cardiovascular disease risk using biomarkers of inflammation. This approach includes the company’s CardioMPO test for circulating myeloperoxidase, the anchor of its proprietary inflammation panel.
August 24, 2011
Technology
August 23, 2011 — Verathon Inc. introduced the Heartscape 3-D Electrocardiogram (ECG) System with 80-lead vest in Europe. It is designed to give emergency department (ED) physicians, interventional cardiologists and ED nurses a more complete diagnostic picture by providing a 360-degree view of the heart.
August 23, 2011
News
August 23, 2011 — A new study shows heart attack patients are now being treated an average of 32 minutes faster than five years ago. This provides evidence a national campaign's success to treat heart attacks within 90 minutes in order to reduce heart damage and costs associated with treatment. This is according to David Holmes, M.D., FACC, president of the American College of Cardiology (ACC).
August 23, 2011Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
News
August 23, 2011 — PLC Systems Inc. said the final results from the REMEDIAL II investigator-sponsored clinical trial have been published online in Circulation, a peer-reviewed journal of the American Heart Association. It will appear in the September 2011 issue of the publication. REMEDIAL II is an Italian trial of the company’s RenalGuard device.
August 23, 2011
News
August 23, 2011 — nContact Inc. has received CE Mark approval for the EPi-Sense Guided Coagulation Device with VisiTrax for the treatment of cardiac arrhythmias, including atrial fibrillation (AF). The EPi-Sense features epicardial sensing electrodes designed to allow both electrophysiologists (EP) and cardiothoracic surgeons to map and navigate the epicardium and locate areas for linear epicardial ablation.
August 23, 2011
News
August 23, 2011— UltraSPECT of Haifa, Israel, announced the sale of more than 10 of its wide beam reconstruction (WBR) software solutions to nuclear pharmaceutical supplier PCI for placement at customer medical facilities throughout Arizona. PCI is a member of United Pharmacy Partners Inc. (UPPI), a nuclear pharmacy network consortium that recently signed a multi-year distribution agreement for the leasing and/or non-exclusive sales of UltraSPECT’s cardiac and bone imaging applications in the United States.
August 23, 2011Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News
August 23, 2011 — Cardium Therapeutics received the final $1.1 million payment from Royal Philips Electronics in connection with Philips' acquisition of Innercool Therapies from Cardium. The purchase gives Philips Healthcare a therapeutic hypothermia product line for use in heart attack, sudden cardiac arrest and neuro trauma patients
August 23, 2011
News
August 19, 2011 - Neovasc Inc. accomplished $4.7 million in financing to complete the COSIRA clinical trial for the Neovasc Reducer to treat refractory angina. The company will also advance the Tiara project to develop a transcatheter device to treat the mitral valve regurgitation.
August 19, 2011
News
August 19, 2011 - Endologix Inc. said a ruling this week will likely aid its defense in a stent graft patent litigation case filed by Cook Medical.
August 19, 2011Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
News
August 19, 2011 — NeoStem Inc., an international biopharmaceutical company, reported progress toward commencement of a Phase II clinical trial for AMR-001 for the treatment of acute myocardial infarction. The stem cell product is from Amorcyte Inc., a NeoStem subsidiary.
August 19, 2011
Feature
August 18, 2011 — The antiplatelet agent prasugrel (trade name Effient), in combination with aspirin, was associated with 26 percent relative risk reduction in cardiovascular death, myocardial infarction or stroke. The results were from a sub-analysis of patients from the TRITON-TIMI 38 study. This was compared to treatment with clopidogrel (trade name Plavix - 8.3 percent vs. 11 percent, respectively, p<0.0001). This corresponds to a 2.7 percent absolute risk reduction for patients treated with prasugrel.
August 19, 2011
Technology
August 18, 2011 – At the 39th Annual AHRA Meeting and Exposition, Fujifilm Medical Systems U.S.A. announced the commercial availability of Synapse Mobility, a zero-footprint application that enables access to Fujifilm's suite of Synapse products from hand-held mobile devices, as well as Macintosh- or Windows-based PCs. Using the Web browser of their choice, radiologists and referring physicians can now have on-the-go access to the images and information stored in Synapse PACS and Synapse RIS, increasing accessibility to patient information and improving workflow.
August 18, 2011© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now